ESR1 and breast cancer: For example, FOXK2 was shown to promote tumor progression by interacting with Dishevelled (DVL) and activating Wnt signaling in colon cancer models (13), but suppressed estrogen receptor–positive breast cancer cell proliferation by interacting with transcriptional corepressor complexes (14).